|
|
|
|
| LEADER |
02184nam a2200337 u 4500 |
| 001 |
EB001865219 |
| 003 |
EBX01000000000000001029299 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190504 r ||| eng |
| 100 |
1 |
|
|a Dias, Sofia
|
| 245 |
0 |
0 |
|a Evidence synthesis in the baseline natural history model
|h Elektronische Ressource
|c report by the Decision Support Unit ; Sofia Dias, Nicky J Welton, Alex J Sutton, AE Ades
|
| 250 |
|
|
|a Updated
|
| 260 |
|
|
|a London
|b National Institute for Health and Clinical Excellence (NICE)
|c April 2012, 2012
|
| 300 |
|
|
|a 1 PDF file (29 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Comparative Effectiveness Research
|
| 653 |
|
|
|a Randomized Controlled Trials as Topic
|
| 653 |
|
|
|a Evidence-Based Medicine
|
| 653 |
|
|
|a Models, Theoretical
|
| 653 |
|
|
|a Treatment Outcome
|
| 700 |
1 |
|
|a Welton, Nicky J.
|e [author]
|
| 700 |
1 |
|
|a Sutton, A. J.
|e [author]
|
| 700 |
1 |
|
|a Ades, A. E.
|e [author]
|
| 710 |
2 |
|
|a National Institute for Health and Clinical Excellence (Great Britain)
|b Decision Support Unit
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a NICE DSU technical support document
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK310368
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This Technical Support Document reviews synthesis issues that arise on the construction of a baseline natural history model. The intention is to cover both the absolute response to treatment on the outcome measures on which comparative effectiveness is defined, and also other elements of the natural history model, which are usually "downstream" of the shorter-term effects reported in trials. The TSDs provide a review of the current state of the art in each topic area, and make clear recommendations on the implementation of methods and reporting standards where it is appropriate to do so. They aim to provide assistance to all those involved in submitting or critiquing evidence as part of NICE Technology Appraisals, whether manufacturers, assessment groups or any other stakeholder type
|